Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (14 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.

Scotland · NHS Scotland MSAN

Lodoxamide 0.1% (Alomide®) eye drops

MSAN(2020)56 · Level 2 · issued 25 Jun 2020

Reference: MSAN(2020)56
Issued: 25 Jun 2020
Priority: Level 2
Valid until: 24 August 2020 as stated by the source
Source: Signed NHS Scotland notice (PDF) ↗

What the notice states

The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.

Product	Position	Resupply
1. Novartis, sole supplier of lodoxamide (Alomide®) 0.1% eye drops, is out of stock until 24th	Out of stock	24th

Provenance

Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.

scot:msan:2020:56

Recorded: 13 Aug 2026 22:03 UTC
Capture route: Captured first-hand by ShortageSignal's scheduled check
Read from: NHS Scotland Medicine Supply Alert Notice (PDF)
Captured at: 13 Aug 2026 22:03 UTC
Content hash: bf608740c94f9e061808e3690524c21b96a9b7256518fec2137a3cbac2333f00
sha256 of the captured bytes — proves what was captured, not that the source was correct
Source document: https://www.publications.scot.nhs.uk/files/msan-2020-56.pdf ↗

From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.